help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0312
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/3/812    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jorgensen, R.
Right arrow Articles by Elling, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jorgensen, R.
Right arrow Articles by Elling, C. E.
Molecular Endocrinology 19 (3): 812-823
Copyright © 2005 by The Endocrine Society

Characterization of Glucagon-Like Peptide-1 Receptor ß-Arrestin 2 Interaction: A High-Affinity Receptor Phenotype

Rasmus Jorgensen, Lene Martini, Thue W. Schwartz and Christian E. Elling

7TM Pharma A/S (R.J., L.M., T.W.S., C.E.E.), Horsholm, DK-2970, Denmark; and Laboratory for Molecular Pharmacology (T.W.S.), The Panum Institute, University of Copenhagen, DK-2100, Denmark

Address all correspondence and requests for reprints to: Christian E. Elling, Ph.D., 7TM Pharma A/S, 2970 Horsholm, Denmark. E-mail: cee{at}7tm.com.

To dissect the interaction between ß-arrestin (ßarr) and family B G protein-coupled receptors, we constructed fusion proteins between the glucagon-like peptide 1 receptor and ßarr2. The fusion constructs had an increase in apparent affinity selectively for glucagon, suggesting that ßarr2 interaction locks the receptor in a high-affinity conformation, which can be explored by some, but not all, ligands. The fusion constructs adopted a signaling phenotype governed by the tethered ßarr2 with an attenuated G protein-mediated cAMP signal and a higher maximal internalization compared with wild-type receptors. This distinct phenotype of the fusion proteins can not be mimicked by coexpressing wild-type receptor with ßarr2. However, when the wild-type receptor was coexpressed with both ßarr2 and G protein-coupled receptor kinase 5, a phenotype similar to that observed for the fusion constructs was observed. We conclude that the glucagon-like peptide 1 fusion construct mimics the natural interaction of the receptor with ßarr2 with respect to binding peptide ligands, G protein-mediated signaling and internalization, and that this distinct molecular phenotype is reminiscent of that which has previously been characterized for family A G protein-coupled receptors, suggesting similarities in the effect of ßarr interaction between family A and B receptors also at the molecular level.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
B. W. Jones and P. M. Hinkle
Arrestin Binds to Different Phosphorylated Regions of the Thyrotropin-Releasing Hormone Receptor with Distinct Functional Consequences
Mol. Pharmacol., July 1, 2008; 74(1): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. D. Holliday, B. Holst, E. A. Rodionova, T. W. Schwartz, and H. M. Cox
Importance of Constitutive Activity and Arrestin-Independent Mechanisms for Intracellular Trafficking of the Ghrelin Receptor
Mol. Endocrinol., December 1, 2007; 21(12): 3100 - 3112.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Jorgensen, V. Kubale, M. Vrecl, T. W. Schwartz, and C. E. Elling
Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor beta-Arrestin Recruitment and Signaling through G{alpha}
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 148 - 154.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
L. Elster, C. Elling, and A. Heding
Bioluminescence Resonance Energy Transfer as a Screening Assay: Focus on Partial and Inverse Agonism
J Biomol Screen, February 1, 2007; 12(1): 41 - 49.
[Abstract] [PDF]


Home page
EndocrinologyHome page
B. Holst, K. L. Egerod, E. Schild, S. P. Vickers, S. Cheetham, L.-O. Gerlach, L. Storjohann, C. E. Stidsen, R. Jones, A. G. Beck-Sickinger, et al.
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
Endocrinology, January 1, 2007; 148(1): 13 - 20.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. A. Syme, L. Zhang, and A. Bisello
Caveolin-1 Regulates Cellular Trafficking and Function of the Glucagon-Like Peptide 1 Receptor
Mol. Endocrinol., December 1, 2006; 20(12): 3400 - 3411.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society